Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Debiec-Rychter

Showing results (91-100 of 207) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
High efficacy of panobinostat towards human gastrointestinal stromal tumors in a xenograft mouse modelGiuseppe Floris, Maria Debiec-Rychter, Raf Sciot, et al.
Journal of Pediatric Surgery|February 24, 2009
Mesenteric lipoblastoma presenting as a segmental volvulusDavid C Yu, Patrick J Javid, Kudakwashe R Chikwava, et al.
Genes, Chromosomes & Cancer|August 31, 2004
Molecular cytogenetic characterization of proximal-type epithelioid sarcomaElena Lualdi, Piergiorgio Modena, Maria Debiec-Rychter, et al.
Pharmacology|March 15, 2006
Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell linesHans Prenen, Gunther Guetens, Gert de Boeck, et al.
Human Pathology|December 20, 2005
Inflammatory myofibroblastic tumor with ALK/TPM3 fusion presenting as ileocolic intussusception: an unusual presentation of an unusual neoplasmAnya N A Milne, Karl J Sweeney, Diarmuid S O'Riordain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutationBarbara Dewaele, Bartosz Wasag, Jan Cools, et al.
Molecular Cancer Therapeutics|August 10, 2011
The heat shock protein 90 inhibitor IPI-504 induces KIT degradation, tumor shrinkage, and cell proliferation arrest in xenograft models of gastrointestinal stromal tumorsGiuseppe Floris, Maria Debiec-Rychter, Agnieszka Wozniak, et al.
Genes, Chromosomes & Cancer|September 23, 2015
A rare mutation in a rare tumor--SMARCB1-deficient malignant glomus tumorBartosz Dabek, Andrzej Kram, Jadwiga Kubrak, et al.
Genes, Chromosomes & Cancer|December 16, 2006
Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational statusAgnieszka Wozniak, Raf Sciot, Louis Guillou, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2015
First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocationChristof Vulsteke, Eveline Lurquin, Maria Debiec-Rychter, et al.
Pageof 21

Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
High efficacy of panobinostat towards human gastrointestinal stromal tumors in a xenograft mouse modelGiuseppe Floris, Maria Debiec-Rychter, Raf Sciot, et al.
Journal of Pediatric Surgery|February 24, 2009
Mesenteric lipoblastoma presenting as a segmental volvulusDavid C Yu, Patrick J Javid, Kudakwashe R Chikwava, et al.
Genes, Chromosomes & Cancer|August 31, 2004
Molecular cytogenetic characterization of proximal-type epithelioid sarcomaElena Lualdi, Piergiorgio Modena, Maria Debiec-Rychter, et al.
Pharmacology|March 15, 2006
Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell linesHans Prenen, Gunther Guetens, Gert de Boeck, et al.
Human Pathology|December 20, 2005
Inflammatory myofibroblastic tumor with ALK/TPM3 fusion presenting as ileocolic intussusception: an unusual presentation of an unusual neoplasmAnya N A Milne, Karl J Sweeney, Diarmuid S O'Riordain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutationBarbara Dewaele, Bartosz Wasag, Jan Cools, et al.
Molecular Cancer Therapeutics|August 10, 2011
The heat shock protein 90 inhibitor IPI-504 induces KIT degradation, tumor shrinkage, and cell proliferation arrest in xenograft models of gastrointestinal stromal tumorsGiuseppe Floris, Maria Debiec-Rychter, Agnieszka Wozniak, et al.
Genes, Chromosomes & Cancer|September 23, 2015
A rare mutation in a rare tumor--SMARCB1-deficient malignant glomus tumorBartosz Dabek, Andrzej Kram, Jadwiga Kubrak, et al.
Genes, Chromosomes & Cancer|December 16, 2006
Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational statusAgnieszka Wozniak, Raf Sciot, Louis Guillou, et al.
Journal of Chemotherapy (Florence, Italy)|June 2, 2015
First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocationChristof Vulsteke, Eveline Lurquin, Maria Debiec-Rychter, et al.
Pageof 21